Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
CIHR - Canada
PubMed
30608896
DOI
10.1200/jco.18.00474
Knihovny.cz E-zdroje
- MeSH
- dědičné nádorové syndromy diagnóza genetika metabolismus MeSH
- DNA vazebné proteiny genetika metabolismus MeSH
- enzymy opravy DNA genetika metabolismus MeSH
- fenotyp MeSH
- genetická predispozice k nemoci MeSH
- genetické testování * MeSH
- homolog 2 proteinu MutS genetika metabolismus MeSH
- kolorektální nádory diagnóza genetika metabolismus MeSH
- lidé MeSH
- mismatch repair endonukleáza PMS2 genetika metabolismus MeSH
- mutace * MeSH
- MutL homolog 1 genetika metabolismus MeSH
- nádorové biomarkery genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory mozku diagnóza genetika metabolismus MeSH
- oprava chybného párování bází DNA * MeSH
- prediktivní hodnota testů MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- DNA vazebné proteiny MeSH
- enzymy opravy DNA MeSH
- G-T mismatch-binding protein MeSH Prohlížeč
- homolog 2 proteinu MutS MeSH
- mismatch repair endonukleáza PMS2 MeSH
- MLH1 protein, human MeSH Prohlížeč
- MSH2 protein, human MeSH Prohlížeč
- MutL homolog 1 MeSH
- nádorové biomarkery MeSH
- PMS2 protein, human MeSH Prohlížeč
PURPOSE: Constitutional mismatch repair deficiency (CMMRD) is a highly penetrant cancer predisposition syndrome caused by biallelic mutations in mismatch repair (MMR) genes. As several cancer syndromes are clinically similar, accurate diagnosis is critical to cancer screening and treatment. As genetic diagnosis is confounded by 15 or more pseudogenes and variants of uncertain significance, a robust diagnostic assay is urgently needed. We sought to determine whether an assay that directly measures MMR activity could accurately diagnose CMMRD. PATIENTS AND METHODS: In vitro MMR activity was quantified using a 3'-nicked G-T mismatched DNA substrate, which requires MSH2-MSH6 and MLH1-PMS2 for repair. We quantified MMR activity from 20 Epstein-Barr virus-transformed lymphoblastoid cell lines from patients with confirmed CMMRD. We also tested 20 lymphoblastoid cell lines from patients who were suspected for CMMRD. We also characterized MMR activity from patients with neurofibromatosis type 1, Li-Fraumeni syndrome, polymerase proofreading-associated cancer syndrome, and Lynch syndrome. RESULTS: All CMMRD cell lines had low MMR activity (n = 20; mean, 4.14 ± 1.56%) relative to controls (n = 6; mean, 44.00 ± 8.65%; P < .001). Repair was restored by complementation with the missing protein, which confirmed MMR deficiency. All cases of patients with suspected CMMRD were accurately diagnosed. Individuals with Lynch syndrome (n = 28), neurofibromatosis type 1 (n = 5), Li-Fraumeni syndrome (n = 5), and polymerase proofreading-associated cancer syndrome (n = 3) had MMR activity that was comparable to controls. To accelerate testing, we measured MMR activity directly from fresh lymphocytes, which yielded results in 8 days. CONCLUSION: On the basis of the current data set, the in vitro G-T repair assay was able to diagnose CMMRD with 100% specificity and sensitivity. Rapid diagnosis before surgery in non-neoplastic tissues could speed proper therapeutic management.
Aga Khan University Hospital Karachi Pakistan
Banner MD Anderson Cancer Center Gilbert AZ
Baylor College of Medicine and Texas Children's Hospital Houston TX
Children Cancer Hospital Karachi Pakistan
Children's Hospital Colorado Aurora CO
Children's Hospital of Philadelphia and University of Pennsylvania Philadelphia PA
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center Pittsburgh PA
Dalhousie University Faculty of Medicine Halifax Nova Scotia Canada
Geisinger Medical Center Danville PA
King Fahad Medical City Riyadh Saudi Arabia
McGill University Health Centre Montréal Quebec Canada
McGill University Montréal Quebec Canada
Medical College of Wisconsin Milwaukee WI
Medical University of South Carolina Charleston SC
Mount Sinai Hospital Toronto Ontario Canada
Ottawa Hospital Research Institute Ottawa Ontario Canada
Princess Margaret Cancer Centre Toronto Ontario Canada
Rambam Health Care Campus Haifa Israel
Ruby Memorial Hospital Morgantown WV
Saint George Hospital University Medical Center Beirut Lebanon
Schneider Children's Medical Center of Israel Petach Tikva Israel
Sheba Medical Center Tel Hashomer Israel
Taipei Veterans General Hospital Taipei Republic of China
Tel Aviv Sourasky Medical Center Tel Aviv Israel
Tel Aviv University Tel Aviv Israel
The Hospital for Sick Children Toronto Ontario Canada
Toronto General Hospital Toronto Ontario Canada
Universidad San Francisco de Quito Quito Ecuador
Université Catholique de Louvain Brussels Belgium
Université Laval Quebec City Quebec Canada
University Hospital Motol Charles University Prague Czech Republic
University of Colorado Anschutz Medical Campus Aurora CO
University of Manitoba Winnipeg Manitoba Canada
University of Texas Southwestern Medical Center Dallas TX
Citace poskytuje Crossref.org